Related Experiment Video
Updated: Jan 11, 2026

Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage
Published on: August 4, 2021
Complicated grief following pregnancy loss in women with autoimmune rheumatic diseases: a comparative cross-sectional
Maria Eugenia Corral-Trujillo1, Rodrigo Cerda-González1, Anahí Carrazco-Chapa1
1University Hospital "Dr. José Eleuterio González", Universidad Autónoma de Nuevo León, (RheumatologyService), Av. Gonzalitos 235, Mitras Centro, Monterrey, 64460, N.L, Mexico.
Abstract:
BACKGROUND: Women with autoimmune rheumatic diseases (ARDs) present a higher rate of obstetric adverse events including perinatal losses (PL). The aim of this study is to determine the frequency of both complicated grief (CG) following PL and resilience in women with ARDs and compare it to a control group. METHODS: We performed an analytical, comparative, cross-sectional study from November 2022 to July 2024. Women with and without an ARD diagnosis with a history of PL who completed a self-report survey including the Perinatal Grief Scale (PGS) and the Wagnild and Young Resilience Scale (RS) were selected. We analyzed sociodemographic data, clinical characteristics, and scale scores with SPSS Version 25. RESULTS: Ninety participants were enrolled in this study. Thirty-three women met criteria for CG following PL, 22 (66.7%) belonged to the control group and 11 (33.3%) to the ARD group (p = 0.016). The RS median score was 138.00 (IQR 117–163). A logistic regression revealed that having an ARD is independently associated with not presenting CG (OR = 0.338; p = 0.018, 95% CI = 0.138–0.829), suggesting that women with ARDs are 2.95 times less likely to develop CG. CONCLUSIONS: Women with ARDs had a lower frequency of CG following PL than the control group. We found no significant difference between groups regarding resilience capacity. The logistic regression suggests that ARDs serve as a protective factor for developing CG following PL. Screening for CG following PL in women with and without ARDs may help optimize maternal and infant health. CLINICAL TRIAL NUMBER: Not applicable.
Related Concept Videos
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Bonanno's Theory of Grieving
Resilience
Rheumatic Heart Disease IV: Nursing Management

